Skip to main content
. 2020 May 22;15(5):e0233503. doi: 10.1371/journal.pone.0233503

Fig 2. Successful recovery of base edited imidazolinone resistant mutants.

Fig 2

a Imidazolinone resistant mutants emerged with pooled T4 seeds were subject to MS medium with imazapic at 0.24 mg/l. b Genotypes of imidazolinone resistant mutants by Sanger sequencing of PCR amplicons. R in red stands for the heterozygosity of base A and G. A in red is homozygous edits. c Imidazolinone resistant alleles revealed by PCR amplicon cloning. Letters in green are modified nucleotides or amino acids.